tiprankstipranks
Advertisement
Advertisement

GMAB Stock Latest News

Genmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market
Company AnnouncementsGenmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market
2h ago
GMAB
Genmab reports Q2 net sales of Darzalex $4.207B
PremiumThe Fly
Genmab reports Q2 net sales of Darzalex $4.207B
5d ago
JNJ
GMAB
Buy Rating Reiterated on Genmab as DARZALEX Franchise Seen Defensible; $40 Price Target Maintained
PremiumRatings
Buy Rating Reiterated on Genmab as DARZALEX Franchise Seen Defensible; $40 Price Target Maintained
7d ago
GMAB
Genmab says EC grants marketing authorization for Tepkinly combo
PremiumThe Fly
Genmab says EC grants marketing authorization for Tepkinly combo
14d ago
ABBV
GMAB
Genmab price target raised to $40 from $38 at H.C. Wainwright
PremiumThe Fly
Genmab price target raised to $40 from $38 at H.C. Wainwright
18d ago
GMAB
Blair adds American Express, Oracle to Conviction List in monthly update
PremiumThe FlyBlair adds American Express, Oracle to Conviction List in monthly update
19d ago
P
CW
Premium
Ratings
Genmab: Buy Rating Reiterated on Strong Epkinly Phase III Data and Late-Stage Pipeline; Price Target Unchanged at DKK 2,500
20d ago
GMAB
Genmab: Strong Phase III EPCORE DLBCL-4 Data and Major Label Expansion Opportunity Reinforce Buy Rating
Premium
Ratings
Genmab: Strong Phase III EPCORE DLBCL-4 Data and Major Label Expansion Opportunity Reinforce Buy Rating
20d ago
GMAB
Genmab Reports Strong Phase 3 Data for Epcoritamab Combo in Relapsed/Refractory DLBCL
PremiumCompany Announcements
Genmab Reports Strong Phase 3 Data for Epcoritamab Combo in Relapsed/Refractory DLBCL
21d ago
6K
GMAB
Genmab announces topline results from EPCORE DLBCL-4 trial
PremiumThe Fly
Genmab announces topline results from EPCORE DLBCL-4 trial
21d ago
ABBV
GMAB
Genmab reports ‘positive’ Phase 3 results from EPCORE DLBCL-4 trial
PremiumThe Fly
Genmab reports ‘positive’ Phase 3 results from EPCORE DLBCL-4 trial
21d ago
GMAB
AbbVie reports ‘positive’ results from Phase 3 EPCORE DLBCL-4 trial
PremiumThe Fly
AbbVie reports ‘positive’ results from Phase 3 EPCORE DLBCL-4 trial
21d ago
ABBV
GMAB
Ram Selvaraju Reiterates Buy on Genmab, Keeps EPKINLY-Driven Outlook with Unchanged $38 Price Target
PremiumRatingsRam Selvaraju Reiterates Buy on Genmab, Keeps EPKINLY-Driven Outlook with Unchanged $38 Price Target
27d ago
GMAB
Genmab Updates Articles of Association, Extends Capital-Raising Powers
Premium
Company Announcements
Genmab Updates Articles of Association, Extends Capital-Raising Powers
1M ago
6K
GMAB
Genmab Announces Minor Capital Increase Following Employee Warrant Exercise
Premium
Company Announcements
Genmab Announces Minor Capital Increase Following Employee Warrant Exercise
1M ago
6K
GMAB
Genmab Discloses Orbis as New 4.99% Major Shareholder
PremiumCompany Announcements
Genmab Discloses Orbis as New 4.99% Major Shareholder
1M ago
6K
GMAB
Genmab Updates Articles of Association to Expand Capital-Raising Flexibility
PremiumCompany Announcements
Genmab Updates Articles of Association to Expand Capital-Raising Flexibility
1M ago
6K
GMAB
Matt Phipps Reiterates Buy on Genmab as Strong Epkinly Data Offset Missed Overall Survival Endpoint and Support Long-Term Upside
PremiumRatings
Matt Phipps Reiterates Buy on Genmab as Strong Epkinly Data Offset Missed Overall Survival Endpoint and Support Long-Term Upside
1M ago
GMAB
Genmab announces new data from studies evaluating epcoritamab
PremiumThe Fly
Genmab announces new data from studies evaluating epcoritamab
1M ago
GMAB
Genmab Grants New Restricted Stock Units and Warrants to Employees
PremiumCompany AnnouncementsGenmab Grants New Restricted Stock Units and Warrants to Employees
1M ago
6K
GMAB
Genmab Trial Setback: Terminated Melanoma Study Adds Uncertainty to GMAB’s Immuno-Oncology Outlook
Premium
Company Announcements
Genmab Trial Setback: Terminated Melanoma Study Adds Uncertainty to GMAB’s Immuno-Oncology Outlook
1M ago
GMAB
Genmab presents EPCORE FL-1 subgroup data at EHA 2026 Congress
Premium
The Fly
Genmab presents EPCORE FL-1 subgroup data at EHA 2026 Congress
1M ago
GMAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >